Wilhelm W, Berg K, Langhammer A, Bauer C, Biedler A, Larsen R
Klinik für Anaesthesiologie und Intensivmedizin, Universitätskliniken des Saarlandes, Homburg/Saar.
Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Sep;33(9):552-6. doi: 10.1055/s-2007-994810.
Rapid post-anaesthetic awakening and low hypnotic potency are two characteristic properties of the new opioid remifentanil. For clinical use remifentanil must be combined with another anaesthetic agent. Propofol is well-established for ambulatory anaesthesia, however, the properties of desflurane (low blood-gas solubility, rapid elimination) suggest this volatile anaesthetic to be a comparable alternative, particularly if rapid awakening is desired. The present study was designed to compare emergence times and haemodynamics for a combination of remifentanil wich hypnotic concentrations of either propofol or desflurane.
Gynaecological patients, scheduled for elective laparoscopy, were studied at random. After oral premedication with diazepam 0.08-0.12 mg/kg, anaesthesia was induced identically in both groups: remifentanil bolus (1 microgram/kg), start of remifentanil infusion (0.5 microgram/kg/min), followed by propofol (approx. 2 mg/kg) and cisatracurium (0.1 mg/kg). For maintenance of anaesthesia remifentanil (0.25 microgram/kg/min) was combined with either desflurane (0.5 MAC = 3.0 vol%) or propofol (6 mg/kg/h). With termination of surgery anaesthetic delivery was discontinued simultaneously and recovery times were recorded. Heart rate and non-invasive blood pressure were recorded at defined points of interest.
In total, 40 patients (desflurane n = 20, propofol n = 20) were studied in comparable groups. For both regimens, emergence after remifentanil-based anaesthesia was remarkably rapid between unconsciousness and complete recovery: In mean only 60 s elapsed from the onset of spontaneous breathing to the moment when patients could clearly state their name. In comparison, recovery times were significantly shorter after remifentanil-desflurane than after remifentanil-propofol: time to spontaneous ventilation 6.4 +/- 2.8 vs. 9.6 +/- 3.9 min (mean +/- SD, p = 0.01); extubation 6.7 +/- 2.8 vs. 9.8 +/- 4.0 min (p = 0.02) and arrival at PACU 11.1 +/- 3.4 vs. 14.7 +/- 4.2 min (p = 0.005). The courses of heart rate (HR) and mean arterial pressure (MAP) were mostly similar in both groups with only minimal or moderate cardiocirculatory reactions during intubation or start of surgery.
Remifentanil in combination with either desflurane or propofol, used for general anaesthesia during gynaecological laparoscopy, will facilitate a smooth haemodynamic course as well as a rapid emergence thereafter. Recovery times after remifentanil-based anaesthesia are significantly shorter with 3.0 vol% of desflurane than with 6 mg/kg/h propofol. Thus, desflurane appears to be a well-suited adjunct to remifentanil and an ideal alternative to propofol, if rapid recovery is required. Differences are best explained by the pharmacological properties of both coanaesthetics and their applied dosages.
快速术后苏醒和低催眠效能是新型阿片类药物瑞芬太尼的两个特性。临床使用时,瑞芬太尼必须与另一种麻醉剂联合使用。丙泊酚已广泛用于门诊麻醉,然而,地氟烷的特性(低血-气溶解度、快速消除)表明这种挥发性麻醉剂是一种可比较的替代药物,特别是在需要快速苏醒的情况下。本研究旨在比较瑞芬太尼与催眠浓度的丙泊酚或地氟烷联合使用时的苏醒时间和血流动力学。
对计划进行择期腹腔镜手术的妇科患者进行随机研究。口服地西泮0.08 - 0.12 mg/kg进行术前用药后,两组患者的麻醉诱导方式相同:静脉注射瑞芬太尼(1微克/千克),开始输注瑞芬太尼(0.5微克/千克/分钟),随后给予丙泊酚(约2毫克/千克)和顺式阿曲库铵(0.1毫克/千克)。维持麻醉时,瑞芬太尼(0.25微克/千克/分钟)与地氟烷(0.5 MAC = 3.0体积%)或丙泊酚(6毫克/千克/小时)联合使用。手术结束时,同时停止麻醉给药并记录苏醒时间。在规定的感兴趣时间点记录心率和无创血压。
总共40例患者(地氟烷组n = 20,丙泊酚组n = 20)被纳入可比组进行研究。对于两种方案,基于瑞芬太尼的麻醉后从无意识状态到完全苏醒的过程都非常迅速:平均而言,从自主呼吸开始到患者能够清楚说出自己名字的时刻仅经过60秒。相比之下,瑞芬太尼 - 地氟烷组的苏醒时间明显短于瑞芬太尼 - 丙泊酚组:自主通气时间6.4 ± 2.8分钟对9.6 ± 3.9分钟(平均值 ± 标准差,p = 0.01);拔管时间6.7 ± 2.8分钟对9.8 ± 4.0分钟(p = 0.02),到达麻醉后恢复室时间11.1 ± 3.4分钟对14.7 ± 4.2分钟(p = 0.005)。两组的心率(HR)和平均动脉压(MAP)变化过程大多相似,在插管或手术开始时仅有轻微或中度的心血管循环反应。
瑞芬太尼与地氟烷或丙泊酚联合用于妇科腹腔镜手术的全身麻醉时,将有助于维持平稳的血流动力学过程以及术后快速苏醒。基于瑞芬太尼的麻醉后,使用3.0体积%地氟烷的苏醒时间明显短于使用6毫克/千克/小时丙泊酚的苏醒时间。因此,如果需要快速恢复,地氟烷似乎是瑞芬太尼的合适辅助药物,也是丙泊酚的理想替代品。差异最好用两种辅助麻醉剂的药理学特性及其应用剂量来解释。